Digital developments and precision medicine in paediatric growth disorder management

Watch OnDemand

Recorded: Thursday 5 November, 2020

Please feedback on your experience

Digital technologies to improve the precision of paediatric growth disorder diagnosis and management

View the article published in the Growth Hormone & IGF Research journal that summarises the webinar discussion on the role of digital health in growth disorders.

Read the Open Access Article Now

Digital developments and precision medicine in paediatric growth disorder management

Despite evidence that digital screening improves the diagnosis of growth disorders, late diagnosis and referral of patients continues to be prevalent.

Professor Savage was joined by growth disorder and digital health specialists to address resistant factors to the adoption of technology, and demonstrate how, despite a lack of published data on the efficacy of digital tools, supporting evidence of their effectiveness in other endocrine disorders, such as diabetes, can also be applied to paediatric growth disorder management.

Topics Speaker
Introduction and current practice gaps in management of short stature Martin Savage
Digital interpretation of primary care height measurements to facilitate early diagnosis Leo Dunkel
Application of digital resources to growth disorder management Luis Luque
Growth hormone adherence management using digital technology Sandro Loche
Summary Martin Savage
Discussion and Q & A All

This webcast is suitable for, but not limited to, clinical paediatric endocrinologists, clinical adult endocrinologists, paediatric endocrine nurses, and all other healthcare professionals interested in the management of growth disorders in childhood and transition.

After watch the webcast, learners will be able to:

  1. Explain current practice gaps in the management of short stature
  2. Gain knowledge of digital programming of primary care height measurement to detect abnormalities of growth.
  3. Gain awareness of and confidence in the use of digital technology to improve management of growth, as well as patient self-management
  4. Debate what can be learnt from the use of digital tools in other endocrine disorders

Emeritus Professor of Paediatric Endocrinology

William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry in London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He is a clinician with clinical and research interests in growth disorders, specifically those with abnormalities in the growth hormone-IGF-1 axis. His main research field has been the phenotype:genotype relationships of GH-IGF-1 axis defects. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.

His other clinical interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. Professor Savage has lectured in 59 countries world-wide and has published over 440 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. He continues to lecture nationally and internationally.

View full disclosure information

Professor of Paediatric Endocrinology

William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK

Following leading professorial paediatric endocrine positions in Helsinki and Kuopio, Leo Dunkel joined Barts Health and SMD as Professor of Paediatric Endocrinology. He trained in Finland and at Stanford, USA and has an outstanding track record in the field of puberty and disorders of the gonadal and growth axes over the last 35 years. Prof Dunkel’s  innovative approach to clinical and translational research has supported numerous clinical fellows to become principal investigators themselves.

View full disclosure information

Cofounder of Adhera Health Inc (USA) and Salumedia Labs (Sevilla, Spain)

USA and Spain

Luis Fernandez-Luque is co-founder of digital therapeutics company Adhera Health Inc (USA), and currently leads operations at its subsidiary Salumedia Labs (Spain). He has over 15 years of experience in digital health research with a strong focus on mobile health for behavioural change. He has worked in digital health initiatives across the globe including the Americas, Europe, Asia and Africa. Dr Fernandez Luque  has served in multiple positions in the International Medical Informatics Association, and is a founder of its working group focused on participatory health and social media.

View full disclosure information

Head of  the Pediatric Endocrinology Unit

Pediatric Hospital Microcitemico, Cagliari, Italy

Sandro Loche received his medical degree at the University of Cagliari in 1979, training in Pediatrics and Endocrinology at the University of Cagliari, and in Pediatric Endocrinology at the Cornell University Medical College, New York. His main areas of scientific interest include: growth and growth disorders, neuroendocrine regulation of GH secretion, diagnosis and treatment of GH deficiency, childhood obesity. Dr Loche has published over 200 articles, reviews and books. He has served as Editor of the Journal of Endocrinological Investigation and is currently associate editor of Frontiers in Endocrinology. He has also served as vice–president for the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED) and as President for the Regional section of the Italian Society of Pediatrics. Dr Loche was awarded the 2015 Cacciari Prize of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED) for excellence in Pediatric Endocrinology.

Dr Loche is a member of the Italian Society of Endocrinology (SIE), SIEDP/ISPED, Italian Society of Pediatrics (SIP), Italian Society of Obesity (SIO), Italian Society of Medical Endocrinology (AME), American Endocrine Society, European Society for Paediatric Endocrinology (ESPE), and European Neuroendocrine Association (ENEA). He has also served on various Committees of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED), the Italian Society of Endocrinology and the Italian Society of Pediatrics, and has been an invited speaker for numerous national and international meetings.

View full disclosure information

This programme is made possible thanks to an educational grant received from: Merck Healthcare KGaA, Darmstadt, Germany

This only applies to the live webinar

The Digital developments and precision medicine in paediatric growth disorder management webinar (live streaming), United Kingdom, 05/11/2020-05/11/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Missed our recent webcasts on growth disorders covering the Asia Pacific and Latin American regions? Click below to watch these now!

Missed our previous webcast on growth disorders and technology? Click below to watch this now!